Frequency and consequence of the recurrent p.T372R mutation in sporadic insulinomas.
作者信息
Parekh Vaishali I, Modali Sita D, Welch James, Simonds William F, Weinstein Lee S, Kebebew Electron, Agarwal Sunita K
机构信息
Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA.
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
出版信息
Endocr Relat Cancer. 2018 May;25(5):L31-L35. doi: 10.1530/ERC-17-0311. Epub 2018 Feb 21.
Abstract
摘要
相似文献
1
Frequency and consequence of the recurrent p.T372R mutation in sporadic insulinomas.散发性胰岛素瘤中复发性p.T372R突变的频率及后果
Endocr Relat Cancer. 2018 May;25(5):L31-L35. doi: 10.1530/ERC-17-0311. Epub 2018 Feb 21.
2
Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.胰岛素瘤的全外显子组测序揭示 YY1 中反复出现的 T372R 突变。
Nat Commun. 2013;4:2810. doi: 10.1038/ncomms3810.
3
Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.散发性胰岛素瘤中体细胞阴阳1突变的频率及临床相关性
J Clin Endocrinol Metab. 2015 May;100(5):E776-82. doi: 10.1210/jc.2015-1100. Epub 2015 Mar 12.
4
Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.胰岛素瘤中阴阳1基因复发性体细胞突变的新功能效应
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4062-7. doi: 10.1073/pnas.1503696112. Epub 2015 Mar 18.
5
T372R Mutation Status in Yin Yang 1 Gene in Insulinoma Patients.胰岛素瘤患者阴阳1基因中的T372R突变状态
Horm Metab Res. 2017 Jun;49(6):452-456. doi: 10.1055/s-0043-107244. Epub 2017 May 4.
6
Neuroendocrine cancer: Insulinomas-recurrent mutations identified in YY1.神经内分泌癌：胰岛素瘤——在YY1中发现复发性突变。
Nat Rev Endocrinol. 2014 Mar;10(3):127. doi: 10.1038/nrendo.2013.259. Epub 2013 Dec 24.
7
Mutation Status in Yin Yang 1 Gene in X-ray-Induced Insulinoma Cell Line Rin-5F.
Pancreas. 2020 Jul;49(6):e49-e50. doi: 10.1097/MPA.0000000000001565.
8
[Expression of YY 1 protein in human insulinoma and its clinical implication].[YY1蛋白在人胰岛素瘤中的表达及其临床意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Mar;36(3):361-4.
9
Significance of the pathogenic mutation T372R in the Yin Yang 1 protein interaction with DNA--thermodynamic studies.阴阳1蛋白与DNA相互作用中致病突变T372R的意义——热力学研究
FEBS Lett. 2016 Mar;590(6):838-47. doi: 10.1002/1873-3468.12106. Epub 2016 Mar 10.
10
Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical Significance.胰腺神经内分泌肿瘤中 YY1 基因的突变和表达及其临床意义。
Endocr Pract. 2021 Sep;27(9):874-880. doi: 10.1016/j.eprac.2021.02.016. Epub 2021 Mar 9.
引用本文的文献
1
Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data.高分化G1和G2胰腺神经内分泌肿瘤：已发表的扩展DNA测序数据的荟萃分析
Front Endocrinol (Lausanne). 2024 May 29;15:1351624. doi: 10.3389/fendo.2024.1351624. eCollection 2024.
2
Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review.转录因子YY1对胰腺内分泌和外分泌肿瘤发生发展的影响：一篇叙述性综述
Cell Biosci. 2021 May 13;11(1):86. doi: 10.1186/s13578-021-00602-8.
3
Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤的分子特征及其临床应用
Front Endocrinol (Lausanne). 2021 Jan 18;11:575620. doi: 10.3389/fendo.2020.575620. eCollection 2020.
4
Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.胃肠胰神经内分泌肿瘤（epi）遗传学的临床应用：迈向液体活检。
Rev Endocr Metab Disord. 2019 Sep;20(3):333-351. doi: 10.1007/s11154-019-09508-w.
5
Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.胃肠胰神经内分泌肿瘤的遗传学和表观遗传学。
Endocr Rev. 2019 Apr 1;40(2):506-536. doi: 10.1210/er.2018-00160.
本文引用的文献
1
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas.通过整合人类胰岛素瘤中的分子图谱深入了解糖尿病的β细胞再生
Nat Commun. 2017 Oct 3;8(1):767. doi: 10.1038/s41467-017-00992-9.
2
T372R Mutation Status in Yin Yang 1 Gene in Insulinoma Patients.胰岛素瘤患者阴阳1基因中的T372R突变状态
Horm Metab Res. 2017 Jun;49(6):452-456. doi: 10.1055/s-0043-107244. Epub 2017 May 4.
3
Whole-genome landscape of pancreatic neuroendocrine tumours.胰腺神经内分泌肿瘤的全基因组图谱。
Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15.
4
Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.胰岛素瘤中阴阳1基因复发性体细胞突变的新功能效应
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4062-7. doi: 10.1073/pnas.1503696112. Epub 2015 Mar 18.
5
Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.散发性胰岛素瘤中体细胞阴阳1突变的频率及临床相关性
J Clin Endocrinol Metab. 2015 May;100(5):E776-82. doi: 10.1210/jc.2015-1100. Epub 2015 Mar 12.
6
GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.GSK-3β 蛋白在胰岛癌细胞中磷酸化并稳定 HLXB9 蛋白，形成一种可靶向的控制胰岛癌细胞增殖的机制。
J Biol Chem. 2014 Feb 28;289(9):5386-98. doi: 10.1074/jbc.M113.533612. Epub 2014 Jan 14.
7
Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.胰岛素瘤的全外显子组测序揭示 YY1 中反复出现的 T372R 突变。
Nat Commun. 2013;4:2810. doi: 10.1038/ncomms3810.
8
Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.阴阳1在肿瘤发生中的机制：间接效应的重要性。
Crit Rev Oncog. 2011;16(3-4):143-61. doi: 10.1615/critrevoncog.v16.i3-4.20.
9
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.DAXX/ATRX、MEN1 和 mTOR 通路基因在胰腺神经内分泌肿瘤中经常发生改变。
Science. 2011 Mar 4;331(6021):1199-203. doi: 10.1126/science.1200609. Epub 2011 Jan 20.
10
Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.在INS-1E胰岛素瘤细胞中进行两年连续培养期间对葡萄糖敏感性和代谢-分泌偶联的研究。
Endocrinology. 2004 Feb;145(2):667-78. doi: 10.1210/en.2003-1099. Epub 2003 Oct 30.
Zotero 插件